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Abstract
Background: While several recent large randomized trials found clinically relevant effects of acupuncture over no
treatment or routine care, blinded trials comparing acupuncture to sham interventions often reported only minor
or no differences. This raises the question whether (sham) acupuncture is associated with particularly potent
nonspecific effects. We aimed to investigate the size of nonspecific effects associated with acupuncture
interventions.
Methods: MEDLINE, Embase, Cochrane Central Register of Controlled Clinical Trials and reference lists were
searched up to April 2010 to identify randomized trials of acupuncture for any condition, including both sham and
no acupuncture control groups. Data were extracted by one reviewer and verified by a second. Pooled
standardized mean differences were calculated using a random effects model with the inverse variance method.
Results: Thirty-seven trials with a total of 5754 patients met the inclusion criteria. The included studies varied
strongly regarding patients, interventions, outcome measures, methodological quality and effect sizes reported.
Among the 32 trials reporting a continuous outcome measure, the random effects standardized mean difference
between sham acupuncture and no acupuncture groups was -0.45 (95% confidence interval, -0.57, -0.34; I
2 = 54%;
Egger’s test for funnel plot asymmetry, P = 0.25). Trials with larger effects of sham over no acupuncture reported
smaller effects of acupuncture over sham intervention than trials with smaller nonspecific effects (b = -0.39, P =
0.029).
Conclusions: Sham acupuncture interventions are often associated with moderately large nonspecific effects
which could make it difficult to detect small additional specific effects. Compared to inert placebo interventions,
effects associated with sham acupuncture might be larger, which would have considerable implications for the
design and interpretation of clinical trials.
Background
In recent years, there has been increasing evidence from
large randomized trials and systematic reviews showing
that patients receiving acupuncture report better out-
comes than patients receiving no treatment or usual
care only (for example, [1,2]). A large trial on low back
pain [3] and a meta-analysis of migraine trials [4] even
found superiority over guideline-oriented conventional
care. At the same time, many recent high-quality trials
comparing true acupuncture with a sham acupuncture
intervention found only minor or even no differences
(see [4-7] for systematic reviews). The interpretation of
this evidence is controversial. Some authors argue that
the better effects over no treatment and usual care are
only due to the usual placebo effects and bias [8]. Some
authors argue that most sham acupuncture interventions
are physiologically active [9,10], and others contend that
sham acupuncture interventions might be associated
with particularly potent nonspecific or placebo effects
[11,12].
Treatment effects are considered specific if they are
attributable solely, according to the theory of the
mechanism of action, to the characteristic component of
an intervention [13,14]. Effects which are associated
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any medium, provided the original work is properly cited.with the incidental elements of an intervention are con-
sidered nonspecific effects (synonymous with placebo
effects). Nonspecific effects are mostly thought to be
due to psychobiological processes triggered by the over-
all therapeutic context [15]. They have to be distin-
guished from the natural course of disease, regression to
the mean, effects of being in a study, cointerventions
and, as far as possible, from reporting and other biases
[16,17]. The total effect of an intervention consists of
both specific and nonspecific effects [18].
Separating characteristic and incidental elements of an
intervention is straightforward in pharmacology, but is
difficult in other interventions such as psychotherapy
[19]. Acupuncture involves the insertion and manipula-
tion of needles into defined points of the body. While a
variety of mechanistic models exist, the exact mechan-
ism of action is unclear [20]. This makes it difficult to
devise a placebo intervention which is both inert and
indistinguishable and reliably separates specific and non-
specific effects. The frequent use of the term sham
intervention instead of placebo partly reflects this pro-
blem. Sham interventions in clinical trials of acupunc-
ture typically vary from “true” acupuncture in one or
both of the following aspects [21]: location of points (for
example, stimulation of nonindicated points or outside
known points) and skin penetration (for example, use of
fixed telescope “placebo” needles with a blunt tip). If
some or most of these sham interventions should indeed
be physiologically active, such trials would not compare
acupuncture to a placebo but to an active intervention,
making it more difficult to detect significant differences.
This problem would also apply if (sham) acupuncture
would be associated with more potent placebo effects
than other interventions. Both invasive and noninvasive
sham acupuncture interventions exert (like true acu-
puncture) mild painful stimuli. It has been hypothesized
that such interventions might trigger enhanced placebo
effects by simultaneously acting on sensory, cognitive
and emotional levels [12]. There is also evidence that
the same sham acupuncture intervention can have quite
different effects when provided in different contexts
[22]. Placebo research indicates that in many situations,
the therapeutic context associated with an intervention
matters more than the placebo intervention itself [15].
The therapeutic context depends not only on the speci-
fic therapeutic ritual applied but also on experiences,
attitudes and preferences of patients and providers, the
patient-provider interaction, the setting and the cultural
background [11]. Given the positive attitudes and expec-
tation toward complementary therapies, it seems possi-
ble that complex rituals such as acupuncture could
provoke significant psychobiological responses.
The most straightforward way to investigate whether
sham acupuncture is associated with larger effects than
a pharmacological placebo would be in randomized
trials including both these interventions. The only trial
using such an approach indeed found a significant
superiority of sham acupuncture [23]. Another, albeit
methodologically weaker, possibility is to compare dif-
ferences between sham acupuncture interventions and
no-treatment control groups in acupuncture trials with
those of (other) placebos and no-treatment control
groups in other trials. Hróbjartsson and Gøtzsche
[24-26] have repeatedly reviewed all available trials,
including both a placebo or sham and a no-treatment
group for any condition. The latest update of their
Cochrane review includes a total of 234 trials. In a pre-
planned subgroup analysis, they found that studies using
“physical placebos” (including sham acupuncture)
reported larger placebo effects (standardized mean dif-
ference (SMD) -0.31; 95% confidence interval (CI) -0.41,
-0.22) than studies using “pharmacological placebos”
(SMD -0.10; 95% CI -0.20, -0.01) [26]. In a reanalysis of
their data, we separated the trials in which the physical
placebo was sham acupuncture from those which used
other physical placebos. Effect sizes were significantly
larger in trials using sham acupuncture than in trials
using other physical placebos (SMDs -0.41 (-0.56, -0.24)
vs -0.26 (-0.37, -0.15); P = 0.007) [27].
The Cochrane review [26] and our reanalysis of these
data did not include a number of recent rigorous, large
acupuncture trials which included both a sham group
and a no-treatment group. Furthermore, these reviews
did not investigate whether large nonspecific effects
might make it difficult to detect specific effects. There-
fore, we have performed a systematic review of acu-
puncture trials in any condition including both sham
and no-treatment groups published through April 2010.
Our primary aim was to investigate the size of nonspeci-
fic effects of acupuncture (difference between sham acu-
puncture vs no acupuncture). Our secondary aims were
to investigate factors (such as type of sham intervention,
condition, study quality or intensity of cointerventions)
possibly influencing the size of such nonspecific effects
and to quantify specific (difference acupuncture vs sham
acupuncture) and total effects of acupuncture (difference
acupuncture vs no acupuncture) in the included trials.
Methods
Selection criteria
To be included, studies had to meet the following cri-
teria: (1) allocation to groups was explicitly randomized;
(2) participants were persons treated for any illness or for
preventative purposes; trials in healthy volunteers mea-
suring physiological outcomes were excluded; (3) inter-
vention involving the insertion of needles described as
acupuncture at acupuncture points, pain or trigger points
with or without stimulation; trials on interventions
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were excluded; (4) sham interventions described as sham,
placebo, dummy or fake treatment which differed from
true acupuncture in at least one of two key aspects (skin
penetration or point location); (5) no-acupuncture con-
trol group had to be a second control group in which
participants received neither true nor sham acupuncture;
participants could be either completely untreated or
receive treatments which were also administered in the
true and sham acupuncture groups (for example, rescue
medication, basic treatment or routine care); and (6) a
clinical outcome for which the calculation of an effect
size estimate was possible.
Data sources and searches
To identify potentially relevant studies, we searched
MEDLINE (from 1966 to April 2010) and Embase (from
1988 to April 2010) for all sham-controlled trials of acu-
puncture (see Additional file 1, Search strategies).
Furthermore, we searched the Cochrane Central Regis-
ter of Controlled Trials using a search strategy based on
a Cochrane review of randomized trials with placebo
and no-treatment controls in all medicine [25]. While
Chinese trials identified by our search were eligible, we
did not search specific Chinese databases. One reviewer
screened titles and abstracts of all references identified
and excluded those which were clearly irrelevant. Full
texts of all remaining articles were obtained and
assessed independently for eligibility by two reviewers.
Disagreements or uncertainties were resolved by
discussion.
Data extraction and quality assessment
One reviewer extracted information on the following
aspects from included studies using a standard form:
diagnosis; recruitment; number and type of study cen-
ters; number and types of intervention and control
groups; details on acupuncture and sham interventions;
how patients were informed about these interventions;
qualification of acupuncturists; cointerventions; study
duration, number of patients randomized, analyzed and
dropping out (per group); age; gender; results on the
main outcome measures; important secondary outcomes
and responder data. A second reviewer checked all
extraction of study results against the original publica-
tions. Trials were considered to have lower risk of bias
if they reported an adequate method of randomization
concealment and had a dropout rate below 15% [28].
For our main analyses, we used the following strategy to
choose the outcome: (1) it should be a continuous out-
come (mean and standard deviation available, or the
standard deviation could be calculated from standard
errors or confidence intervals, for example; we did not
impute standard deviations for studies without available
data on variability or precision); (2) the timing should
be as close as possible to the completion of treatment;
(3) when there was a clearly predefined main outcome
measure, we chose this measure (but always preferred
the measurement at the end of treatment over other
time points or change from baseline); (4) when there
was no predefined single main outcome measure, two
reviewers independently chose the outcome considered
most important (two disagreements were resolved by
discussion); (5) If available, we used intention to treat
data; otherwise, we used the data as presented in the
publication. If a trial had more than one intervention
(for example, an individualized and a standardized inter-
vention) or more than one sham group, the data were
pooled. For more recent studies, we tried to contact
authors to inquire for further information if data for
meta-analysis were missing.
Data synthesis and analysis
The Cochrane Collaboration’s Review Manager RevMan
5 software was used for meta-analyses. Three compari-
sons were investigated: sham acupuncture versus no
acupuncture (primary comparison), acupuncture versus
sham acupuncture, and acupuncture versus no acupunc-
ture. Studies were categorized into the clinical categories
of chronic pain studies, short-term studies (that is, stu-
dies with an observation period of less than 3 days), and
other studies.
The main analysis was based on trials reporting a con-
tinuous outcome measure using the standardized mean
difference (SMDs; difference between the means/pooled
standard deviation) as an effect size estimate. As we
assumed that studies would be clinically heterogeneous,
a random effects model with the inverse variance
method was used for meta-analysis. Negative SMDs
indicated a beneficial effect of sham acupuncture over
no acupuncture, acupuncture over sham acupuncture
and acupuncture over no acupuncture, respectively.
SMDs ≤ -0.4 were considered small effects, those
between -0.41 and -0.7 were considered moderate effects
and those > -0.7 were considered large effects [29]. To
investigate statistical heterogeneity, RevMan 5 uses
Tau
2, Chi
2 and I
2. We considered I
2 values between 30%
and 60% as indicating moderate heterogeneity and
higher values as indicating substantial heterogeneity.
Subgroup comparisons were performed using the
method described by Deeks et al. [30] and implemented
in RevMan 5. Egger’s test was used to assess funnel plot
asymmetry [31].
To check the robustness of results, we performed sen-
sitivity analyses (1) including three-armed studies which
had been excluded because they did not meet all inclu-
sion criteria, but still could be considered because they
addressed the questions investigated in this review
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outcomes for studies with more than one relevant out-
come at the completion of treatment; and (3) using
dichotomous outcome measures (with a relative risk <1
indicating a beneficial effect).
For exploratory analyses, we defined further sub-
groups: larger (at least 100 patients) and smaller (< 100
patients) comparisons; lower and higher risk of bias (see
data extraction and quality assessment); studies with
intense or less intense cointerventions in all study arms,
with and without skin penetration (and depending on
where needles were placed) in sham groups; studies
with and without a clearly defined main outcome mea-
sure; and studies describing sham in the consent proce-
dure as another treatment or placebo. In multivariate
random effects meta-regression analyses, we investigated
simultaneously the influence of risk of bias, cointerven-
tions, skin penetration in the sham group and condition
(chronic pain vs others). Analyses were carried out
using the restricted information maximum likelihood
(REML) method. For meta-regression analyses, PASW
versions 17.0 and 18.0 software (SPSS, Chicago, IL,
USA) using additional macros described by Wilson was
used [32]. To investigate the hypothesis that there is an
inverse correlation between specific and nonspecific
effects (that is, trials with large nonspecific effects are
less likely to find large specific effects than are trials
with small nonspecific effects), we performed a linear
regression analysis using the inverse of the squared
pooled standard error as a weighting factor.
Results
Literature search and selection
The literature search identified a total of 1854 refer-
ences, of which 1779 were excluded in the screening
process as they clearly did not meet the inclusion cri-
t e r i a( s e eF i g u r e1 ) .T h ef u l lt e x to ft h er e m a i n i n g7 5
references was formally assessed for eligibility. A total of
1854 references screened 
1779 excluded based on 
screening of titles and  
      a b s t r a c t s    
75 publications read in full text and assessed for eligibility 
      18  did  not  meet  selection  criteria 
          2  study  protocols  without  results 
          2  abstracts  with  insufficient  inf. 
          5  “borderline”  studies 
37 studies (37 main and 11 additional publications) included: 
32 with continuous data outcome, 24 with binary outcome, 19 both 
Figure 1 Flow chart.
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additional publications reported protocols or treatment
details of trials included in the review or reported the
same results in another language (see Additional file 1,
Table S1). Eighteen articles did not meet the inclusion
criteria, and two were protocols of ongoing trials (see
Additional file 1, Table S2). Two abstracts reported
minimal information on probably eligible trials including
results for a dichotomous outcome [70,71]; attempts to
obtain further information from the authors were
unsuccessful. In four other studies, patients in the no-
acupuncture control group received minor interventions
not provided in the other two groups [72-75]. Finally,
for one study presenting an asymmetric confidence
interval for the continuous main outcome measure, we
were unable to unambiguously calculate the standard
deviation [76]. The latter five trials were included in a
sensitivity analysis as “borderline” studies.
Description of included studies
The 37 eligible trials included a total of 5754 patients
(median 75, minimum 30, and maximum 638). Fourteen
trials (3369 patients) addressed chronic pain or a condi-
tion associated with chronic pain (Table 1); eight were
short-term trials with a duration of less than 3 days
(522 patients; Table 2) investigating whether acupunc-
ture is helpful for sedation, anxiety, pain or nausea asso-
ciated with surgical operations, endoscopic interventions
or labor; and 15 trials (1863 patients) addressed a variety
of other conditions (Table 3). Ten of the 14 chronic
pain trials, but only six of the remaining 23 studies,
reported an adequate method of allocation concealment.
Dropout rates were between 54% and 95% in three
addiction trials, but low in most other studies. Ten
chronic pain trials and three trials of other conditions
reported an adequate method of allocation concealment
and a dropout rate below 15% and were classified as
having a lower risk of bias.
Fifteen studies had a clearly predefined main outcome
measure. For 32 trials, a continuous effect size measure
could be calculated, and for 24 trials a dichotomous
effect size measure (for 19 trials both a continuous and
a dichotomous effect size measure could be calculated).
Acupuncture interventions varied strongly regarding
number of sessions, type of acupuncture (that is, classi-
cal acupuncture, electroacupuncture, ear acupuncture),
level of individualization for point selection and number
of needles used. In 31 trials, the sham procedure
involved skin penetration (in 7 trials at acupuncture
points not indicated for the condition treated and in 24
trials outside known acupuncture points); six trials used
approaches without skin penetration (in three trials at
the same points as in the acupuncture group and in
three trials outside known points).
Meta-analysis of nonspecific effects (sham acupuncture vs
no acupuncture)
The main analyses are based on the 32 trials reporting
data on a continuous outcome. For the comparison of
sham acupuncture with no acupuncture, the pooled
SMDs were -0.53 (95% CI -0.67, -0.39) among chronic
pain trials, -0.23 (-0.50, 0.04) among short-term studies
and -0.42 (95% CI -0.66, -0.18) in other studies (Figure
2). The test for differences between diagnostic sub-
groups missed statistical significance at the 5% level (P
= 0.08). Effect sizes showed moderate statistical hetero-
geneity among chronic pain studies, no heterogeneity
among short-term studies and marked heterogeneity
among the other studies. If studies were pooled across
clinical subgroups, the SMD was -0.45 (95% CI -0.57,
-0.34). In seven trials, effects over no-treatment groups
were large (SMDs were above -0.7); in nine trials, these
effects were moderate (between -0.4 and -0.7); and in 16
trials, these effects were small (< -0.4). Results were
similar when borderline studies were included, when in
studies without a predefined main outcome measure
other outcomes were chosen or when dichotomous out-
comes were analyzed (see Additional file 1, Table S3).
Egger’s test did not suggest funnel plot asymmetry (P =
0.25; asymmetry coefficient 0.21) (Figure 3). In explora-
tory subgroup analyses (see Additional file 1, Table S3),
effect sizes differed significantly according to the level of
cointervention (larger if less cointerventions) and
according to the type of sham intervention (larger if no
skin penetration). Nonspecific effects tended to be larger
in trials with a larger sample size, a lower risk of bias,
and a clearly predefined outcome, but the differences
were not statistically significant. In multivariate meta-
regression analyses, only the association with level of
cointerventions approached statistical significance (P =
0.07). Trials with larger effects of sham over no acu-
puncture reported smaller effects of acupuncture over
sham intervention than trials with smaller nonspecific
effects (b = -0.39, P = 0.029).
Meta-analysis of specific effects (acupuncture vs sham
acupuncture) and total effects (acupuncture vs no
acupuncture)
For the comparison of acupuncture with sham acupunc-
ture, the pooled random effects SMDs were -0.46 (95%
CI -0.72, -0.20) for chronic pain studies, -0.34 (95% CI
-0.79, 0.12) for short-term studies, and -0.28 (-0.59,
0.03) for other studies (see Additional file 1, Figure S1).
There were no statistically significant (P = 0.71) differ-
ences between diagnostic subgroups, but there was sub-
stantial statistical heterogeneity in all three clinical
categories. If trials were pooled across categories, the
SMD was -0.37 (95% CI -0.55, -0.19). The funnel plot
was highly asymmetrical (Additional file 1, Figure S2; P
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Trial Clinical problem Sample size (%
dropout rate)
Concealment Outcome used for meta-
analysis
Intervention
details
Standard basic care
in all groups
Birch &
Jamison [38]
Chonic myofascial neck
pain
46
(22%)
Unclear Change from baseline on pain
intensity rating scale
N:14
D:30
T:12w
Ac:C
JA
S:I C 2
NSAIDs if needed
Brinkhaus et
al. [39]
Chronic low-back pain 298
(6%)
Adequate PMOM: VAS pain intensity week
8
N:12
D:30
T:8w
Ac:B
CA
S:I B 1
NSAIDs if needed
Cherkin et al.
[42]
Chronic low-back pain 638
(5%)
Adequate PMOM: Roland Morris Disability
Questionnaire week 8
N:10
D:20
T:7w
Ac1:A
CA
Ac2:C
CA
S:C II
3
Self-care book, usual
care as needed
Facco
a et al.
[44]
Migraine 160
(21%)
Adequate
b Migraine Disability Index (MIDAS)
at 3 months
N:20
D:30
T:11w
Ac:A
CA
S1:II A
3
S2:II C
3
Rizatriptan for attacks
in all patients
Foster et al.
[46]
Osteoarthritis of the
knee
352
(7%)
Adequate WOMAC pain scale at 6 weeks
(PMOM: 6 months)
N:6
D:30
T:3w
Ac:A
CA
S:II A
3
Individual exercise,
advice, NSAIDs if
needed
d
Helms [49] Primary dysmenorrhea 48
(10%)
Unclear Monthly pain score week 12 N:9
D:30
T:12w
Ac:C
CA
S:I C 1
No treatment
Kotani et al.
[51]
Treatment-resistant
pain at abdominal
scares
70
(0)
Adequate VAS intensity continuous pain
after treatment
N:20
D
c
T:4w
Ac:A
TA
S:I A 1
Diclofenac as
necessary
Lee & Lee
[52]
Chronic prostatitis/
chronic pelvic pain
39
(19%)
Unclear PMOM: Change NIH-Chronic
Prostatitis Symptom Index
N:12
D:20
T:6w
Ac:C
EA
S:I C 1
Advice and basic
exercises
Leibing et al.
[53]
Chronic low-back pain 131
(13%)
Unclear Decrease intensity of pain (VAS)
at 12 weeks
N:20
D:30
T:12w
Ac:C
CA
S:I C 1
26 sessions
standardized
physiotherapy
d
Linde et al.
[56]
Migraine 302
(9%)
Adequate PMOM: Days with at least
moderate headache in weeks 9
to 12
N:12
D:30
T:8w
Ac:B
CA
Sc:I B
1
Attack medication as
needed
Melchart et
al. [58]
Tension-type headache 270
(8)%
Adequate PMOM: Number of days with
headache in weeks 9 to 12
N:12
D:30
T:8w
Ac:B
CA
S:I B 1
Pain medication as
needed
Molsberger et
al. [59]
Chronic low-back pain 186
(6%)
Adequate VAS pain intensity after 1 month
(dichotomous PMOM)
N:12
D:30
T:4w
Ac:B
CA
S:I C 1
Orthopedic
rehabilitation
program
d
Suarez-
Almazor
a et
al. [64]
Osteoarthritis of the
knee
535
(8%)
Adequate
b WOMAC pain scale at 3 months N:12
D:20
T:6w
Ac:C
CA
S:I C 1
NSAIDs and analgesics
as before study
Witt et al.
[67]
Osteoarthritis of the
knee
294
(5%)
Adequate PMOM: WOMAC total score after
baseline at 8 weeks
N:12
D:30
T:8w
Ac:B
CA
S:I B 1
NSAIDs if needed
aTwo sham groups with different context.
bAdditional information received from author.
cTreatment with intradermal needles.
dClassified as intense
cointervention likely to influence the outcome. PMOM, explicitly predefined (regarding type and timing) confirmatory main outcome measure; VAS, visual
analogue scale; N, number of treatment sessions; D, duration of each treatment session; T, total duration of treatment in weeks; Ac, Acupuncture; S, sham
intervention; A, individualized; B, semistandardized; C, standardized; CA, needling at classical acupuncture body points; EA, electroacupuncture (needles
stimulated with electrical currency); EarA, ear acupuncture (needling at ear points); JA, Japanese acupuncture (superficial needling); TA, acupuncture at trigger
points; I, penetrating; II, nonpenetrating; 1, needled outside known points; 2, acupuncture points not indicated for condition needled; 3, at correct points; NSAIDs,
nonsteroidal anti-inflammatory drugs; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
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yielded significantly less positive results than smaller
trials (SMDs -0.15 (95% CI -0.31, 0.01) vs -0.59 (95% CI
-0.93, -0.24); P < 0.001). Specific effects were also smal-
ler in trials with lower risk of bias and more intense
cointerventions, while skin penetration and condition
did not have a significant influence.
The pooled SMDs between acupuncture and no acu-
puncture were -0.94 (95% CI -1.20, -0.67) for chronic
pain studies, -0.60 (95% CI -1.08, -0.12) for short-term
studies, and -0.63 (-0.91, -0.35) for other studies (see
Additional file 1, Figure S3) with marked heterogeneity
in all three categories. If all studies were pooled, the
SMD was -0.77 (95% CI -0.94, -0.59). There was signifi-
cant funnel plot asymmetry (P = 0.03; asymmetry coeffi-
cient -0.38), with smaller studies yielding larger effect
estimates (Additional file 1, Figure S4, for the funnel
plot).
Discussion
Summary of main findings
According to our findings (sham) acupuncture interven-
tions are often associated with noteworthy nonspecific
effects. Differences between sham acupuncture and no-
acupuncture groups tended to be smaller in trials in
which there were intense cointerventions in all study
groups. Indicators of study quality (that is, sample size,
risk of bias, predefinition of a main outcome measure)
were not associated significantly with effect size. Trials
with larger effects of sham over no acupuncture
reported smaller effects of acupuncture over sham inter-
vention than trials with smaller nonspecific effects. In
our analyses, we also found small to moderate specific
effects of acupuncture interventions over sham acupunc-
ture; however, trials with large sample size and low risk
of bias yielded less positive results. In our study set, the
total effect of acupuncture interventions including both
specific and nonspecific effects was, on average, at least
moderate in size.
Strengths and limitations
Although we did not systematically search Chinese lan-
guage databases, our review is currently the most com-
prehensive and largest analysis of randomized trials of
acupuncture including both a sham and a no-treatment
control group. It includes many more and larger trials
than previous analyses [26-28]. The overall findings are
highly robust to sensitivity analyses and indicators of
study quality. The most important limitation of our
review is the strong heterogeneity of our trial set regard-
ing patients, interventions, outcomes and methodologi-
cal quality. We do not think that pooling such a
Table 2 Characteristics of included trials: Short-term trialsa
Trial Clinical problem Sample
size
(%
dropout)
Concealment Outcome used for meta-
analysis
Intervention
details
Standard basic care in all
groups
Cabrini
et al. [41]
Bronchoscopy 48
(0)
Unclear VAS discomfort after
bronchoscopy
N:1
D:20
T:-
Ac:C
CA
S:I C 1
Lidocaine as needed
Dundee
et al. [43]
Perioperative nausea (minor
gynecologic operations)
75
(0)
Unclear Number of patients vomiting N:1
D:5
T:-
Ac:C
CA
S:I C 1
Premedication 10 mg
nalbophine
Fanti et al.
[45]
Colonoscopy 30
(0)
Unclear Satisfaction with sedation using a
verbal rating scale
N:1
D:4
T:-
Ac:C EA
S:I C 1
Midazolam 0.02 mg/kg
before and during
colonoscopy
b
Gioia et al.
[48]
Sedation during cataract
surgery
75
(0)
Unclear Postoperative anxiety evaluation
(VAS)
N:1
D:60
T:-
Ac:C
CA
S:I C 1
Topical eye anesthesia
(lidocaine 4%)
Karst et al.
[50]
Anxiety and tooth
extraction
48
(0)
Unclear VAS anxiety N:1
D:25
T:-
Ac:C
EarA
S:II C 1
Local anesthesia (articaine
hydrochloride)
Li et al.
[55]
Colonoscopy 36
(0)
Unclear VAS pain intensity N:1
D:30
T:-
Ac:C EA
S:I C 1
Routine analgesia and
sedation as needed
Rusy et al.
[62]
Postoperative nausea after
tonsillectomy
120
(0)
Unclear Incidence of nausea, vomiting,
rescue therapy in first 24 hours
N:1
D:20
T:-
Ac:C EA
S:I C 2
Standardized anesthesia,
analgesia as needed
Ziaei &
Hayipour
[69]
Pain reduction and
relaxation during labor
90
(unclear)
Unclear VAS pain after 2 hours N:1
D:n.
i..
T:-
Ac:C
CA
S:I C 1
Unclear
aSee Table 1 footnotes for definitions of abbreviations.
bClassified as intense cointervention likely to influence the outcome.
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Page 7 of 14heterogeneous set of studies would be adequate if the
aim were primarily to assess effectiveness for clinical
decision making. However, our primary aim was to
investigate whether (sham) acupuncture interventions
are, on average, associated with relevant nonspecific
effects. To assess the size of nonspecific effects, it is
necessary to include trials with both a sham and a no-
acupuncture control group. As the number of such trials
is limited, pooling all available information can be justi-
fied for generating hypotheses and has been performed
in the Cochrane review on placebo effects in all condi-
tions in a much more radical manner [26].
The comparisons between sham acupuncture and acu-
puncture in the primary studies included in our review
Table 3 Characteristics of included trials: Trials on various other conditions
a
Trial Clinical problem Sample size
(% dropout)
Concealment Outcome used for meta-
analysis
Intervention
details
Standard basic care in all
groups
Allen
et al. [33]
Depression 38
(11%)
Unclear Hamilton Rating Scale for
Depression after 8 weeks
N:12
D:n.i.
T:8w
Ac:A
CA
S:I A 2
Probably no treatment at all
Allen
et al. [34]
Depression 157
(13%)
Unclear Hamilton Rating Scale for
Depression after 8 weeks
(PMOM)
N:12
D:20
T:8w
Ac:A
CA
S:I A 2
Probably no treatment at all
Asher
et al. [35]
Induction of labor 89
(0)
Adequate PMOM: Time to delivery N:7
D:30
T:2w
Ac:C
CA
S:I A 1
Routine prenatal care
Aune
et al. [36]
Recurrent urinary tract
infections
67
(unclear)
Unclear Patients without infection N:8
D:20
T:4w
Ac:A
CA
S:I C 1
No treatment
Avis et al.
[37]
Menopausal hot flashes 56
(0)
Adequate
b Reduction in hot flash
frequency
b
N:16
D:30
T:8w
Ac:B
CA
S:B A
2
Continuation of nondrug
treatment used before trial
Bullock
et al. [40]
Addiction (cocaine abuse) 236
(59%)
Unclear Addiction severity scale drug
use in week 8
N:28
D:45
T:8w
Ac:C
EarA
S:I C 2
Eden psychosocial
programming
d
Freire
et al. [47]
Moderate obstructive
sleep apnea syndrome
36
(28%)
Unclear Apnea-hypopnea index after
12 weeks
N:10
D:30
T:10w
Ac:C
CA
S:I C 1
Offer to receive sleep
hygiene counseling
Lembo
b
et al. [54]
Irritable bowel syndrome
(IBS)
231
(8%)
Adequate PMOM: IBS Global
Improvement Scale week 3
N:6
D:20
T:3w
Ac:B
CA
S:II B
1
Continuation of drugs and
diet used before trial
Medici
et al. [57]
Stable chronic asthma 66
(0)
Unclear PMOM: Peak expiratory flow
variability baseline to 4
months
N:16
D:20
T:8w
Ac:C
CA
S:I C 1
Asthma drugs adapted if
necessary
d
Rampes
et al. [60]
Addiction (alcohol abuse) 59
(54%)
Adequate
c PMOM: VAS craving for alcohol
after 8 weeks
N: 6
D: 30
T: 6w
Ac:C
EarA
S:I C 2
Individual counseling and
group therapy
d
Röschke
et al. [61]
Depression 70
(unclear)
Unclear Responder according to Global
Assessment Scale (GAS)
N: 12
D: 30
T: 4w
Ac:C
CA
S:I C 1
Mianserin 90 to 120 mg/day
in all groups
d
Smith
et al. [63]
Nausea and vomiting
during pregnancy
445
(25%)
Adequate Rhodes Index of Nausea after
4 weeks
N: 5
D: 20
T: 4w
Ac:A
CA
S:I C 1
Pretrial treatment continued;
lifestyle recommendations
Tremeau
et al. [65]
Cervical maturation 37th
to 38th pregnancy week
98
(18%)
Unclear PMOM: Bishop score baseline
to 10 days
N: 3
D: 20
T: 1w
Ac:C
CA
S:I C 1
None
Wang
et al. [66]
Low-back and pelvic pain
during pregnancy
159
(4%)
Adequate
c PMOM: VAS pain change after
1 week
c
N: 1
D:
c
T: 1w
Ac:C
EA
S:I C 2
Acetaminophen and other
self-care if needed
Worner
et al. [68]
Addiction (alcohol abuse) 56
(95%)
Unclear Patients with either relapse or
inpatient detoxification
N: n.i.
D: 30
T:
12w
Ac:C
CA
S:II C
1
Counseling and group
therapy
d
aSee Table 1 footnotes for definitions of abbreviations
bTwo sham groups with different context.
cAdditional information received from author.
dClassified as
intense cointervention likely to influence the outcome.
n.i. = no information reported
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Page 8 of 14are unblinded. As almost all trials focused on patient-
reported outcome measures, there is considerable risk of
bias. Patients randomized to the no-treatment group
might be disappointed and experience “nocebo” effects,
or they might give overly negative ratings for subjective
symptoms. On the other hand, patients randomized to
no-treatment groups might use larger doses of rescue
medication or cointerventions which would lead to an
underestimation of the differences. In fact, in some of
the trials included in our review, patients in no-acu-
puncture control groups had higher analgesic use than
patients in the sham groups (for example, [56,58]).
Insufficient blinding is also a problem for the compari-
son between acupuncture and placebo acupuncture [28].
However, if patients find out that they are in a sham
group, one would expect an underestimation of the
effect of sham over no treatment. In summary, it is diffi-
cult to assess to what extent and in which direction
biases can distort effect estimates between sham and
no-acupuncture groups. It is noteworthy that although
indicators of study quality were not significantly asso-
ciated with the size of nonspecific effects, better and lar-
ger studies tended to report larger effects. It seems that
our estimate of nonspecific effects is less subject to
small study bias and other biases than those for specific
and total effects.
Interpretation
Our findings are highly consistent with smaller analyses
available in the literature [27,28]. The reanalysis of
the 21 acupuncture trials included in the Cochrane
review on placebo effects yielded a SMD of -0.41 [27].
Study or Subgroup
1.1.1 Chronic pain studies
Birch 1998
Brinkhaus 2006
Cherkin 2009
Facco 2007
Foster 2007
Helms 1987
Kotani 2001
Lee 2009
Leibing 2001
Linde 2005
Melchart 2005
Molsberger 2002
Suarez-Almazor 2010
Witt 2005
Subtotal (95% CI)
Heterogeneity: Tau² = 0.03; Chi² = 24.68, df = 13 (P = 0.03); I² = 47%
Test for overall effect: Z = 7.37 (P < 0.00001)
1.1.2 Short term studies
Cabrini 2006
Fanti 2003
Gioia 2006
Karst 2006
Li 1991
Ziaei 2006
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 4.57, df = 5 (P = 0.47); I² = 0%
Test for overall effect: Z = 1.68 (P = 0.09)
1.1.3 Other studies
Allen 1998
Allen 2006
Asher 2009
Avis 2008
Bullock 1999
Freire 2006
Lembo 2009
Medici 2002
Rampes 1997
Smith 2002
Tremeau 1992
Wang 2009
Subtotal (95% CI)
Heterogeneity: Tau² = 0.10; Chi² = 32.95, df = 11 (P = 0.0005); I² = 67%
Test for overall effect: Z = 3.39 (P = 0.0007)
Total (95% CI)
Heterogeneity: Tau² = 0.05; Chi² = 67.22, df = 31 (P = 0.0002); I² = 54%
Test for overall effect: Z = 7.53 (P < 0.00001)
Mean
-0.75
43.7
5.4
6.25
5.98
102.88
5.7
-3.5
-2.1
2.6
10.8
36
31
36.3
61.7
-86.7
31
3.21
3
7.43
-2.9
11.5
9.3
-0.5269
0.23
24.6
-4.87
-0.203
2.8
3.7
-0.89
-23
SD
1.34
29.8
4.9
2.4
4.3
95.4
1.4
3.6
2.2
2.4
8.3
19
19.1
21.88
24
10
20
2.74
1
1.6
7.9
6.7
6.04
0.6321
0.11
11
1.31
0.325
3.12
2.8
1.27
26
Total
13
70
162
61
115
12
23
12
45
76
57
61
302
73
1082
16
10
25
19
12
30
112
11
45
29
17
79
7
75
23
12
148
39
54
539
1733
Mean
0.64
58.6
8.9
9
6.86
79.37
6.4
-3.5
-1
4.3
16.3
39
42.4
49.98
66.6
-83.3
39
5.71
2.7
7.6
-6.1
19
11.9
-0.3203
0.25
28.2
-3.7
-0.095
8.2
5
-1.08
-19
SD
1.96
25.1
6
3.1
4.2
103.16
1.7
2.4
1.7
2.2
7.4
21
16.8
16.7
28
12.2
25
2.83
1
1.9
10.9
8.6
6.29
0.6151
0.1
18
1
0.306
3.13
3
1.38
23
Total
12
74
161
34
105
12
24
12
46
65
63
60
72
67
807
16
10
25
10
12
30
103
11
44
30
17
78
9
77
18
5
149
25
47
510
1420
Weight
1.6%
4.4%
5.5%
3.5%
5.1%
1.6%
2.6%
1.7%
3.7%
4.3%
4.1%
4.2%
5.1%
4.3%
51.7%
2.0%
1.4%
2.7%
1.6%
1.6%
3.0%
12.5%
1.5%
3.5%
3.0%
2.1%
4.6%
1.2%
4.4%
2.4%
0.8%
5.4%
3.1%
3.9%
35.8%
100.0%
IV, Random, 95% CI
-0.81 [-1.63, 0.01]
-0.54 [-0.87, -0.21]
-0.64 [-0.86, -0.41]
-1.02 [-1.47, -0.58]
-0.21 [-0.47, 0.06]
0.23 [-0.57, 1.03]
-0.44 [-1.02, 0.14]
0.00 [-0.80, 0.80]
-0.56 [-0.97, -0.14]
-0.73 [-1.07, -0.39]
-0.70 [-1.07, -0.33]
-0.15 [-0.51, 0.21]
-0.61 [-0.87, -0.35]
-0.70 [-1.04, -0.35]
-0.53 [-0.67, -0.39]
-0.18 [-0.88, 0.51]
-0.29 [-1.17, 0.59]
-0.35 [-0.91, 0.21]
-0.88 [-1.68, -0.07]
0.29 [-0.52, 1.09]
-0.10 [-0.60, 0.41]
-0.23 [-0.50, 0.04]
0.32 [-0.52, 1.17]
-0.97 [-1.41, -0.53]
-0.42 [-0.93, 0.10]
-0.32 [-1.00, 0.35]
-0.19 [-0.50, 0.12]
-0.22 [-1.21, 0.77]
-1.00 [-1.34, -0.66]
-0.33 [-0.96, 0.29]
-1.64 [-2.86, -0.42]
-0.45 [-0.68, -0.22]
0.14 [-0.36, 0.65]
-0.16 [-0.55, 0.23]
-0.42 [-0.66, -0.18]
-0.45 [-0.57, -0.34]
Sham acupuncture No acupuncture Std. Mean Difference Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Favours sham acupuncture Favours no acupuncture
Figure 2 The nonspecific effect of acupuncture (difference between groups receiving sham acupuncture and no acupuncture).S D ,
standard deviation; Total, number of patients; 95% CI, 95% confidence interval; IV, inverse variance method; Random, random effects model; df,
degrees of freedom.
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Page 9 of 14Owing to slightly different inclusion criteria, five trials
were excluded from the current analyses. A meta-analy-
sis by Madsen et al. [28], who reviewed 13 three-armed
trials on acupuncture for acute and chronic pain, found
a SMD of -0.42. Nine of the studies included in their
review were also included in our review, while we
excluded four trials due to slightly different selection
criteria. Our main analysis includes 23 additional trials
(including seven trials addressing chronic or acute pain).
It has been argued that sham interventions in which
needles penetrate the skin (particularly if applied in the
same dermatomes as the true acupuncture intervention)
are physiologically not inert and therefore should not be
considered as placebos [10]. Our exploratory subgroup
analyses (as well as similar analyses in the review by
Madsen et al. [ 2 8 ] )d on o tp r o v i d ee v i d e n c et h a ts h a m
interventions involving needle penetration are associated
with larger nonspecific effects than those which do not.
Thus the limited available data suggest that skin pene-
tration or no skin penetration does not seem to make a
big difference.
If acupuncture should have indeed relevant total
effects but only very limited specific effects, this would
have major implications for the conduct and interpreta-
tion of clinical trials. On the basis of our data and avail-
able systematic reviews [4-7,28], it seems reasonable to
assume an average SMD of 0.4 (or more) for nonspecific
effects and SMD of 0.2 (or less) for specific effects at
least for a number of conditions. To achieve 80% power,
a two-armed, sham-controlled clinical trial investigating
a specific effect of 0.2 SMD would have to recruit about
800 patients. This suggests that almost all available trials
comparing true and sham acupuncture would be
underpowered.
One could argue that a SMD of 0.2 is clinically irrele-
vant. In line with that reasoning, Madsen et al. [28] ques-
tioned in their review whether “the prevailing hypothesis
that acupuncture has an important effect on pain in gen-
eral.” (page 7). However, we believe that another conclu-
sion is possible, too. As we did, Madsen et al. found, on
average, a moderately large effect of sham interventions
over no-acupuncture groups, and both reviews found at
least small specific effects of acupuncture over sham inter-
ventions. The total effect of acupuncture seems to be at
least moderate in size in a number of conditions, and such
effects can well be clinically relevant. For many established
Subgroups
Chronic pain studies
Short term studies
Other studies
-2 -1 0 1 2
0
0.2
0.4
0.6
0.8
1
SMD
SE(SMD)
Figure 3 Funnel plot of studies comparing sham acupuncture versus no acupuncture. SE, standard error; SMD, standardized mean
difference.
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Page 10 of 14drug treatments, SMDs over placebo are in the range
between 0.3 and 0.5 (for example, [77,78]). If, as the avail-
able data suggest [26], clinical effects associated with phar-
macological placebos are small compared to no treatment
(with a SMD of 0.1 on average), the total effects of these
treatments could be in a similar range (around a SMD of
0.4 to 0.6) as those of several acupuncture interventions. It
could be argued that for a suffering individual, it does not
matter whether relief is due to specific or nonspecific
effects. However, as the evidence for larger nonspecific
effects of acupuncture compared to other treatments
comes with one exception [23] from indirect comparisons
open to confounding, firm conclusions are not yet
possible.
We think that our findings are of major relevance to
the question how the clinical effectiveness of complex
nondrug interventions should be assessed. It is likely
that nonspecific effects vary between different types of
complex treatment interventions. The concept of speci-
fic and nonspecific effects might not be fully adequate
in that case, as so-called nonspecific effects might turn
out to be characteristic for a given therapeutic setting. If
the total effect of an intervention in clinical practice
would indeed consist of variable contributions of speci-
fic and nonspecific effects, it could be that a treatment
which has only minor or even no specific but clinically
relevant nonspecific effects has a larger total effect than
a treatment with moderate specific but only minor non-
specific effects. This has been denoted the efficacy para-
dox [79]. Should such a treatment be readily available?
The position of a pragmatic decision maker could be
yes if the comparative treatment represents adequate
standard treatment. In fact, in Germany, acupuncture is
routinely reimbursed for chronic low-back pain as in a
large randomized trial acupuncture (but also sham acu-
puncture which is not reimbursed) was more effective
than treatment based on German guidelines [3]. Skepti-
cal scientists would argue that these results are likely to
be biased because of lack of blinding and that acupunc-
ture should not be considered effective. Furthermore, if
issues such as expectancies, beliefs and trust should
have a relevant influence on the effectiveness of a treat-
ment, the findings of clinical trials might no longer be
valid when attitudes in a population change over time.
Conclusions
Sham acupuncture interventions are often associated
with moderately large nonspecific effects, which could
make it difficult to detect small additional specific
effects. Compared to inert placebo interventions, effects
associated with sham acupuncture might be larger,
which would have considerable implications for the
design and interpretation of clinical trials. Total effects
of acupuncture interventions including both specific and
nonspecific effects often seem to be at least moderate in
size. We believe that there has to be a discussion invol-
ving scientists, decision makers, health care providers
and patients whether and when the evidence for clini-
cally relevant total effects from nonblinded comparisons
is sufficient to consider a treatment effective, even if
specific effects due to the postulated mechanism of
action might be minor or even nonexistent.
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